Jane Street
ARTL icon

Jane Street’s Artelo Biosciences ARTL Stock Holding History

Jane Street’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3K Buy
7,371
+5,918
+407% +$152K ﹤0.01% 10759
2026
Q1 		$99.1K Buy
+1,453
New +$61.8K ﹤0.01% 10659
2021
Q2 		– Sell
-9
Closed -$34K – 9736
2021
Q1 		$34K Buy
+9
New +$34.6K ﹤0.01% 8907

Other funds holding ARTL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Jane Street's ARTL Position: Q2 2026 in Review

Jane Street increased its Artelo Biosciences (ARTL) stake by 407% in Q2 2026, buying an estimated $152K and bringing the position to 7,371 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #10759.

Jane Street first reported a position in ARTL in Q1 2021 and has held it in 3 quarters since. The position peaked at $99.1K in Q1 2026. 7 funds tracked by Wall St. Rank hold ARTL as of Q2 2026.

  • Jane Street held 7,371 shares of Artelo Biosciences worth $74.3K as of Q2 2026.
  • Jane Street bought 5,918 Artelo Biosciences shares in Q2 2026, an estimated $152K.
  • Artelo Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10759 holding.
  • Jane Street first reported a position in Artelo Biosciences in Q1 2021 and has held it in 3 quarters since.
  • Jane Street's Artelo Biosciences position peaked at $99.1K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Artelo Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.